1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Poland Pharmaceuticals and Healthcare Report Q3 2016

Poland Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 86 pages

Includes 3 FREE quarterly updates

BMI View: Poland will remain one of the most attractive pharmaceutical and healthcare markets in theCEE region. Strong economic growth and the introduction of a tax-funded healthcare system will supportstrong market growth. Opportunities for innovative drugmakers will be significant, with an ageingpopulation and increasing accessibility for advanced treatment. However, the potential for the formation ofa Visegrad joint medicine agreement with the Czech Republic, Hungary and Slovakia pose both upside anddownside risks to innovative drugmakers should it go ahead, as joint purchasing initiatives tend to bringpricing pressures which would boost sales whilst reducing profit margins.Headline Expenditure Projections

- Pharmaceuticals: PLN33.39bn (USD8.85bn) in 2015 to PLN34.90bn (USD8.58bn) in 2016; +4.5% inlocal currency terms and -3.1% in US dollar terms. Forecast revised downwards from last quarter.

- Healthcare: PLN114.50bn (USD30.37bn) in 2015 to PLN120.79bn (USD29.71bn) in 2016; +5.5% inlocal currency terms and -2.2% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Poland Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Poland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Poland 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 18
Prescription Drug Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 23
Generic Drug Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Poland 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Poland 2014-2020) 30
Industry Risk Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q3 2016 31
Poland Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Advertising Regulations 40
Other Regulatory Developments 41
Intellectual Property Regime 42
Pricing And Reimbursement 44
Pricing Regime 45
Reimbursement Regime 47
Market Overview 54
Healthcare Sector 55
Table: Civilian Outpatient Facilities, 2002-2009 57
Table: Healthcare Resources (Poland 2010-2015) 58
Table: Healthcare Personnel (Poland 2010-2015) 59
Table: Healthcare Activity (Poland 2010-2015) 59
Research and Development 62
Clinical Trials 62
Epidemiology 64
Competitive Landscape 66
Research-Based Industry 66
Table: Multinational Market Activity 67
Pharmaceutical Distribution 68
Pharmaceutical Retail Sector 69
Table: Number Of Pharmacies In Poland, 2004-2009 70
Company Profile 71
Bioton 71
Polpharma 73
Demographic Forecast 75
Demographic Outlook 75
Table: Population Headline Indicators (Poland 1990-2025) 76
Table: Key Population Ratios (Poland 1990-2025) 76
Table: Urban/Rural Population and Life Expectancy (Poland 1990-2025) 77
Table: Population By Age Group (Poland 1990-2025) 77
Table: Population By Age Group % (Poland 1990-2025) 78
Glossary 80
Methodology 82
Pharmaceutical Expenditure Forecast Model 82
Healthcare Expenditure Forecast Model 82
Notes On Methodology 83
Risk/Reward Index Methodology 84
Index Overview 85
Table: Pharmaceutical Risk/Reward Index Indicators 85
Indicator Weightings 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.